Epilepsy, familial focal, with variable foci 1 (FFEVF1): A Patient Guide

Familial Focal Epilepsy with Variable Foci 1 (FFEVF1) is a rare, inherited condition that affects how the brain regulates electrical activity. At its core, it is caused by pathogenic variants in the DEPDC5 gene, which normally acts as a “brake” on a growth and activity pathway in the brain known as mTOR ^[1]. When this genetic brake is missing or weakened, brain cells can become overactive, leading to the development of focal seizures. Because this condition is inherited in an autosomal dominant pattern, the genetic variant can be passed down through generations, yet it behaves with a unique unpredictability that often surprises families ^[2].

At a Glance:

• Inheriting the gene: A person has a 50% chance of inheriting the variant from an affected parent, or it can occur de novo (spontaneously).
• Developing seizures: The defining characteristic is “variable foci,” meaning the starting point of a seizure can differ significantly between family members ^[3].
• Incomplete penetrance: Not everyone who carries the DEPDC5 variant will develop epilepsy. While some cohorts suggest about 68% of carriers will have seizures, others may never experience a single event ^[4].

This diversity in symptoms is often explained by the proposed “two-hit hypothesis.” While a person is born with one mutated copy of the gene in all their cells, a second, spontaneous mutation may occur in a single brain cell during development ^[5]. This “second hit” can lead to a localized area of abnormal brain tissue called Focal Cortical Dysplasia (FCD), which acts as the source of the seizures. Because this second event happens by chance, some family members may have a visible brain malformation on an MRI, while others have a completely normal-looking brain despite having the same underlying genetic susceptibility ^[6].

Living with FFEVF1 requires a proactive and vigilant approach to care. Most patients begin treatment with standard anti-seizure medications, but some will find that their seizures are difficult to control with drugs alone ^[7]. When two different appropriately chosen medications fail to provide seizure freedom, it is a critical signal to pursue a specialized presurgical evaluation at a comprehensive epilepsy center. Despite being a genetic condition, many patients with a clearly identified “focus” are excellent candidates for surgery, which can offer a high chance of long-term seizure freedom ^[8].

Safety is a paramount concern for families. Developing a clear Seizure Action Plan with your medical team is essential. Discuss known risks, such as nocturnal seizures and SUDEP, as well as incompletely characterized phenomena like ictal central apnea (breathing pauses during seizures) ^[9]. While the path through a FFEVF1 diagnosis involves navigating many uncertainties, the combination of genetic insights, advanced imaging, and specialized treatment options provides a structured framework for managing the condition and supporting a high quality of life ^[10].